Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRSS1 | P07477 | 1/20 | 0.42 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.42 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 4/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | GFER | P55789 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 2/20 | 0.40 |
| ▸ | HTT | P42858 | 4/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.39 |
| ▸ | CES2 | O00748 | 1/20 | 0.39 |
| ▸ | CES1 | P23141 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 6/20 | 0.37 |
| ▸ | POLB | P06746 | 2/20 | 0.37 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.37 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.37 |
| ▸ | RELA | Q04206 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6706899 | 1.00 | PRSS1 (0.42) | PRSS1PRSS2PRSS3HSD17B10LMNA | |
| SCHEMBL6706099 | 0.78 | HSD17B10 (0.46) | HSD17B10LMNAKMT2ATP53HTT | |
| SCHEMBL10753245 | 0.78 | HSD17B10 (0.46) | HSD17B10LMNAKMT2ATP53HTT | |
| SCHEMBL6706101 | 0.78 | HSD17B10 (0.46) | HSD17B10LMNAKMT2ATP53HTT | |
| SCHEMBL17966195 | 0.76 | HSD17B10 (0.45) | HSD17B10KMT2ATP53SMN1; SMN2POLB | |
| SCHEMBL17966196 | 0.76 | HSD17B10 (0.45) | HSD17B10KMT2ATP53SMN1; SMN2POLB | |
| SCHEMBL2259817 | 0.75 | MAPT (0.37) | PRSS1PRSS2PRSS3LMNAKMT2A | |
| SCHEMBL2259819 | 0.75 | MAPT (0.37) | PRSS1PRSS2PRSS3LMNAKMT2A | |
| SCHEMBL7786971 | 0.73 | HSD17B10 (0.36) | HSD17B10LMNAKMT2AL3MBTL1TP53 | |
| SCHEMBL7781768 | 0.73 | PDE4A (0.54) | KMT2ASMN1; SMN2MAPTPOLBALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6770420-B2 | Alkylsulfonyloximes for high-resolution i-line photoresists of high sensitivity | CIBA SPECIALTY CHEMICALS CORPORATION | 2004-08-03 | — | — | US | disclosed |
| US-20040013974-A1 | Alkylsulfonyloximes for high-resolution i-line photoresists of high sensitivity | DIETLIKER KURT (CH) | 2004-01-22 | — | — | US | disclosed |
| EP-0925529-B1 | ALKYSULFONYLOXIMES FOR HIGH-RESOLUTION I-LINE PHOTORESISTS OF HIGH SENSITIVITY | CIBA SC HOLDING AG (CH) | 2003-04-16 | — | — | EP | disclosed |
| EP-0925529-A1 | ALKYSULFONYLOXIMES FOR HIGH-RESOLUTION I-LINE PHOTORESISTS OF HIGH SENSITIVITY | Ciba SC Holding AG (CH) | 1999-06-30 | — | — | EP | disclosed |
| WO-1998010335-A1 | ALKYSULFONYLOXIMES FOR HIGH-RESOLUTION I-LINE PHOTORESISTS OF HIGH SENSITIVITY | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 1998-03-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040013974-A1 | Alkylsulfonyloximes for high-resolution i-line photoresists of high sensitivity | SULT1E1, CCNT1, CCNE1 | PRSS1 968/4885PRSS2 783/4885PRSS3 987/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.